Aimmune Therapeutics, Inc., a biopharmaceutical company developing treatments for potentially life-threatening food allergies, announced that it has entered into a $170 million loan agreement with an affiliate of KKR, a leading global investment firm...
Read Story
January 07, 2019, 07:20 AM
|
Danaher Corporation entered into a new $1 billion 364-day revolving credit facility with Bank of America, N.A., as Administrative Agent, and a syndicate of lenders from time to time party thereto. The Credit Facility expires on March 22, 2019....
Read Story
March 28, 2018, 07:13 AM
|
Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of solutions to advance life science, announced that the Company has completed the previously announced acquisition of Data Sciences International, Inc. (DSI)....
Read Story
February 02, 2018, 07:11 AM
|